Inhibition of biofilm formation in Mycobacterium smegmatis by Parinari curatellifolia leaf extracts

被引:17
作者
Bhunu, Benjamin [1 ]
Mautsa, Ruvimbo [1 ]
Mukanganyama, Stanley [1 ]
机构
[1] Univ Zimbabwe, Dept Biochem, Biomol Interact Anal Grp, POB MP 167, Harare, Zimbabwe
来源
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2017年 / 17卷
关键词
Parinari curatellifolia; Biofilm formation; Mycobacterium smegmatis; Tuberculosis; Isoniazid; Kanamycin; MEDICINAL-PLANTS; TUBERCULOSIS; PATHOGENESIS; RESISTANCE; ZIMBABWE; DRUGS;
D O I
10.1186/s12906-017-1801-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Tuberculosis (TB) is a serious public health problem worldwide. Mycobacterium tuberculosis (M. tuberculosis) grows as drug tolerant pellicles. Agents that inhibit biofilm formation in M. tuberculosis have the potential to reduce the disease treatment period and improve the quality of tuberculosis chemotherapy. Parinari curatellifolia (P. curatellifolia) leaf extracts are claimed to treat symptoms similar to tuberculosis in ethnomedicinal practices. Mycobacterium smegmatis (M. smegmatis) is a surrogate organism used in antimycobacterial drug discovery assays. In this study, the effect of the leaf extracts of P.curatellifolia on M.smegmatis growth and biofilm formation was investigated in order to determine the basis of its use in traditional medicinal use. Methods: Phytochemicals from P. curatellifolia leaves were prepared using a mixture of 50% dichloromethane (DCM): 50% methanol and by serial exhaustive extraction using different solvents of decreasing polarity. The solvents were used in the following order, hexane > dichloromethane > ethyl acetate > acetone > ethanol > methanol > water. The micro-broth dilution method was used as an antimycobacterial susceptibility test to screen for the extract that effectively inhibited M. smegmatis growth and biofilm formation. Biofilm quantification was performed by staining the biofilms with crystal violet and determining the amount of the stain using a spectrophotometer. In addition, the effects of combining the most active extract with kanamycin were also investigated. Results: The minimum inhibitory concentrations (MIC) of the extracts were found to be 6.2 mu g/ml for the acetone extract, 12.5 mu g/ml for both the ethanol and the total extract and 50 mu g/ml for both the methanol and ethyl acetate extracts. The ethanol extract, dichloromethane extract and water extract were the only extracts that effectively inhibited biofilm formation in M.smegmatis. Combining the ethanol extract with kanamycin enhanced the effect of the ethanol extract in terms of inhibition of biofilm formation. Conclusions: P.curatellifolia leaves contain phytochemicals that have the potential to be used both as antimycobacterial and anti-biofilm formation compounds.
引用
收藏
页数:10
相关论文
共 49 条
  • [1] Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis
    Ackart, David F.
    Hascall-Dove, Laurel
    Caceres, Silvia M.
    Kirk, Natalie M.
    Podell, Brendan K.
    Melander, Christian
    Orme, Ian M.
    Leid, Jeff G.
    Nick, Jerry A.
    Basaraba, Randall J.
    [J]. PATHOGENS AND DISEASE, 2014, 70 (03): : 359 - 369
  • [2] Intracellular bacterial biofilm-like pods in urinary tract infections
    Anderson, GG
    Palermo, JJ
    Schilling, JD
    Roth, R
    Heuser, J
    Hultgren, SJ
    [J]. SCIENCE, 2003, 301 (5629) : 105 - 107
  • [3] [Anonymous], 2014, WHO GLOB TUB REP 201
  • [4] Barchan A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P399
  • [5] Barua C.C., 2014, SAJ PHARM PHARM, V1, P101, DOI DOI 10.18875/2375-2262.1.101
  • [6] Basaraba RJ, 2008, TUBERCULOSIS EDINBUR, pS135
  • [7] Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs
    Blanco, Delia
    Perez-Herran, Esther
    Cacho, Monica
    Ballell, Lluis
    Castro, Julia
    Gonzalez del Rio, Ruben
    Luis Lavandera, Jose
    Remuinan, Modesto J.
    Richards, Cindy
    Rullas, Joaquin
    Jesus Vazquez-Muniz, Maria
    Woldu, Ermias
    Cleofe Zapatero-Gonzalez, Maria
    Angulo-Barturen, Inigo
    Mendoza, Alfonso
    Barros, David
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 1868 - 1875
  • [8] A new evolutionary scenario for the Mycobacterium tuberculosis complex
    Brosch, R
    Gordon, SV
    Marmiesse, M
    Brodin, P
    Buchrieser, C
    Eiglmeier, K
    Garnier, T
    Gutierrez, C
    Hewinson, G
    Kremer, K
    Parsons, LM
    Pym, AS
    Samper, S
    van Soolingen, D
    Cole, ST
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) : 3684 - 3689
  • [9] Casterton JW, 1991, SCIENCE, V284, P1318
  • [10] Chigora P., 2007, J. Sust. Dev. Afr, V9, P1509